Susquehanna International »

Enlivex Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-03-31 $388k 102k 3.79
2023-09-30 $38k 24k 1.58
2023-06-30 $157k 60k 2.63
2023-03-31 $407k 112k 3.64
2022-12-31 $942k 242k 3.90
2022-09-30 $1.6M 372k 4.25
2022-06-30 $632k 140k 4.53
2022-03-31 $516k 92k 5.61
2021-12-31 $596k 95k 6.29
2021-09-30 $2.0M 199k 9.88
2021-06-30 $1.2M 131k 8.89
2021-03-31 $3.1M 278k 11.08
2020-12-31 $466k 55k 8.43